Back to search results

AMBET and PCT for PTSD After Cardiac Arrest

This study is looking at two types of talk therapy, Acceptance and Mindfulness-Based Exposure Therapy (AMBET) and Present Centered Therapy (PCT), to see which one better helps people with post-traumatic stress disorder (PTSD) after a cardiac arrest. You might be able to join if you are between 18 and 81 years old, speak English, had a cardiac arrest more than three months ago, and have significant PTSD symptoms. The study wants to find out if AMBET can reduce PTSD symptoms and how it compares to PCT. The study is currently recruiting about 90 participants.

Study design
This interventional study will randomly assign participants to receive either AMBET or PCT. It aims to enroll 90 participants.
What's involved
You will attend 12 hours of individual therapy sessions over about 12 weeks, complete weekly online surveys, and wear a Fitbit device.
Compensation
Not stated in the trial record.
Follow-up
Your PTSD symptoms will be measured at 6 weeks, and then approximately 3 and 6 months after treatment ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07410481

Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)

Recruiting
NAAges 18–81InterventionalTreatment
Columbia University
~90 participants
Updated 2026-04-09 on ClinicalTrials.gov
What's tested:Acceptance and Mindfulness Based Exposure TherapyPresent-Centered Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in PTSD symptoms over time
Measured over Baseline, At 6 weeks, Post-treatment: Approximately 3 months and 6 months from intake

Conditions

PTSD - Post Traumatic Stress Disorder
Cardiac Arrest (CA)

Explore related trials

Cardiac ArrestPost-Traumatic Stress Disorder

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Yuval Neria, PhD · PRINCIPAL_INVESTIGATOR · Columbia University
  • Maja Bergman, PhD · STUDY_DIRECTOR · Columbia University

Who to contact

Yuval Neria, Ph.D.
[email protected]
212-543-6061
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Change in PTSD symptoms over timeBaseline, At 6 weeks, Post-treatment: Approximately 3 months and 6 months from intake

    Change in symptoms as measured by the Clinician Administered PTSD Scale (CAPS-5) from pre- to post-treatment. The full score range is 0 - 80, where lower scores indicate lower symptom levels of PTSD.